 Trisiani Affandi
Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histidine Kinase | 2 | 2019 | 33 | 1.250 |
Why?
| | DNA Breaks, Double-Stranded | 2 | 2024 | 30 | 1.010 |
Why?
| | F-Box Proteins | 1 | 2024 | 20 | 0.960 |
Why?
| | Sirtuins | 1 | 2024 | 34 | 0.950 |
Why?
| | DNA Repair | 2 | 2024 | 198 | 0.900 |
Why?
| | Radiation Injuries, Experimental | 1 | 2021 | 24 | 0.780 |
Why?
| | Silver | 2 | 2019 | 27 | 0.780 |
Why?
| | Salivary Glands | 1 | 2021 | 32 | 0.780 |
Why?
| | Periplasm | 1 | 2019 | 10 | 0.690 |
Why?
| | Copper | 1 | 2019 | 102 | 0.640 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2021 | 407 | 0.610 |
Why?
| | Escherichia coli | 2 | 2019 | 758 | 0.580 |
Why?
| | Metals | 1 | 2016 | 111 | 0.540 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 811 | 0.510 |
Why?
| | Protein Kinase C-delta | 3 | 2022 | 69 | 0.400 |
Why?
| | Signal Transduction | 2 | 2019 | 4709 | 0.330 |
Why?
| | Dimerization | 2 | 2019 | 183 | 0.300 |
Why?
| | DNA Damage | 2 | 2019 | 357 | 0.290 |
Why?
| | Cell Survival | 2 | 2020 | 1047 | 0.280 |
Why?
| | Escherichia coli Proteins | 2 | 2019 | 170 | 0.250 |
Why?
| | DNA End-Joining Repair | 1 | 2024 | 15 | 0.240 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 59 | 0.230 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 93 | 0.230 |
Why?
| | Protein Kinase C-alpha | 1 | 2022 | 43 | 0.210 |
Why?
| | Imatinib Mesylate | 1 | 2021 | 64 | 0.200 |
Why?
| | Dasatinib | 1 | 2021 | 46 | 0.190 |
Why?
| | Protein Kinase C | 1 | 2022 | 297 | 0.190 |
Why?
| | Apoptosis | 2 | 2020 | 2484 | 0.180 |
Why?
| | Chromatin | 1 | 2024 | 441 | 0.180 |
Why?
| | Homologous Recombination | 1 | 2019 | 22 | 0.180 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2019 | 13 | 0.170 |
Why?
| | Models, Animal | 1 | 2021 | 363 | 0.170 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2019 | 71 | 0.170 |
Why?
| | Protein Structure, Quaternary | 1 | 2019 | 116 | 0.170 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 160 | 0.160 |
Why?
| | Protein Domains | 1 | 2019 | 212 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 401 | 0.150 |
Why?
| | Circular Dichroism | 1 | 2016 | 139 | 0.140 |
Why?
| | Trans-Activators | 1 | 2019 | 373 | 0.140 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 332 | 0.140 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 173 | 0.140 |
Why?
| | Proteomics | 1 | 2020 | 876 | 0.130 |
Why?
| | Phosphorylation | 1 | 2019 | 1633 | 0.120 |
Why?
| | Cells, Cultured | 1 | 2021 | 4077 | 0.110 |
Why?
| | Prostatic Neoplasms | 1 | 2019 | 940 | 0.100 |
Why?
| | Cation Transport Proteins | 1 | 2012 | 99 | 0.100 |
Why?
| | Membrane Transport Proteins | 1 | 2012 | 136 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4908 | 0.100 |
Why?
| | Mice | 2 | 2021 | 15520 | 0.080 |
Why?
| | Neoplasms | 1 | 2020 | 2179 | 0.070 |
Why?
| | Humans | 6 | 2024 | 118972 | 0.070 |
Why?
| | Animals | 2 | 2021 | 33381 | 0.050 |
Why?
| | Friends | 1 | 2022 | 49 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2022 | 345 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2019 | 828 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 625 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2019 | 569 | 0.030 |
Why?
| | Female | 1 | 2021 | 61564 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2851 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 200 | 0.030 |
Why?
| | Kinetics | 1 | 2012 | 1624 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 1975 | 0.020 |
Why?
| | Male | 1 | 2019 | 57801 | 0.010 |
Why?
|
|
Affandi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|